Identification | Back Directory | [Name]
Bicyclo[3.1.0]hexane-1-carboxamide, 4-[2-[2-(5-chloro-2-thienyl)ethynyl]-6-(ethylamino)-9H-purin-9-yl]-2,3-dihydroxy-N-methyl-, (1S,2R,3S,4R,5S)- | [CAS]
1784714-67-5 | [Synonyms]
MRS8028 Bicyclo[3.1.0]hexane-1-carboxamide, 4-[2-[2-(5-chloro-2-thienyl)ethynyl]-6-(ethylamino)-9H-purin-9-yl]-2,3-dihydroxy-N-methyl-, (1S,2R,3S,4R,5S)- | [Molecular Formula]
C21H21ClN6O3S | [MOL File]
1784714-67-5.mol | [Molecular Weight]
472.95 |
Hazard Information | Back Directory | [Uses]
MRS8028 is an agonist for A3 adenosine receptor (A3AR), which binds hA3AR with Ki of 2.44 nM. MRS8028 is potential for ameliorating ischemia and inflammatory diseases[1]. | [References]
[1] Tosh D K, et al. 2-Substituted (N)-Methanocarba A3 Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo Characterization[J]. ACS Pharmacology & Translational Science, 2024. |
|
Company Name: |
Biorbyt Ltd.
|
Tel: |
+44 (0)1223 859 353 |
Website: |
http://www.biorbyt.com |
|